Literature DB >> 33468181

Direct anterior approach versus posterolateral approach in total hip arthroplasty: a meta-analysis of results on early post-operative period.

Xuedong Sun1, Xueli Zhao2, Licheng Zhou1, Zheng Su3.   

Abstract

BACKGROUND: This study was performed to compare the advantage and disadvantage of posterolateral approach (PLA) and direct anterior approach (DAA) in total hip arthroplasty (THA).
METHODS: Relevant trials were identified via a search of the Cochrane Central Register of Controlled Trials and PubMed from inception to 1 June 2019. A meta-analysis was performed to compare postoperative perioperative and radiographic outcomes between DAA and PLA in THA with respect to the hospital stay, blood loss, incision length, operative time, complications, and femoral and cup component position. The Harris Hip Score (HHS) was also assessed before and after 6 months postoperatively.
RESULTS: Nine eligible studies involving 22698 adult patients (DAA group, n = 2947; PLA group, n = 19751) were identified for analysis. Compared with the PLA group, the DAA group had shorter hospital stay and achieved better HHS within 6 months after operation (P < 0.05), but the HHS was no significant differences between the two groups over 6 months (P > 0.05). The DAA group had significantly longer operative time, more blood loss, and complications than the PLA group (P < 0.05). In addition, the femoral component positioned in neutral and cup component inclination angle was comparable between both groups (P > 0.05); however, cup component anteversion angle was significantly larger in the PLA group (P < 0.05).
CONCLUSION: Patients in the DAA group had higher HHS within 6 months and shorter hospital stay. The DAA could offer rapid early functional recovery after THA compared with the PLA. However, the DAA group often required longer operative time and had more blood loss. Furthermore, there was a higher early complication rate. Therefore, we believe that the direct anterior approach was a more difficult technique. The surgeon should be a well-trained joint surgeon with extensive prior hip replacement experience before performing THA through a DAA, and DAA was not suitable for beginners performing THA. In addition, we did not observe the difference with regard to the femoral component position and cup component inclination angle except for the smaller cup component anteversion angle in DAA group.

Entities:  

Keywords:  Direct anterior approach; Meta-analysis; Posterolateral approach; Total hip arthroplasty

Mesh:

Year:  2021        PMID: 33468181      PMCID: PMC7816494          DOI: 10.1186/s13018-021-02218-7

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.677


  33 in total

1.  What is the learning curve for the anterior approach for total hip arthroplasty?

Authors:  Richard Noel de Steiger; Michelle Lorimer; Michael Solomon
Journal:  Clin Orthop Relat Res       Date:  2015-12       Impact factor: 4.176

2.  The history of the anterior approach to the hip.

Authors:  Franz Rachbauer; Michael S H Kain; Michael Leunig
Journal:  Orthop Clin North Am       Date:  2009-07       Impact factor: 2.472

3.  Muscle damage during minimally invasive total hip arthroplasty: cadaver-based evidence that it is significant.

Authors:  Sebastien Parratte; Mark W Pagnano
Journal:  Instr Course Lect       Date:  2008

4.  Enhanced early outcomes with the anterior supine intermuscular approach in primary total hip arthroplasty.

Authors:  Keith R Berend; Adolph V Lombardi; Brian E Seng; Joanne B Adams
Journal:  J Bone Joint Surg Am       Date:  2009-11       Impact factor: 5.284

5.  Direct anterior approach versus posterolateral approach in total hip arthroplasty : one surgeon, two approaches.

Authors:  B Fransen; M Hoozemans; S Vos
Journal:  Acta Orthop Belg       Date:  2016-08       Impact factor: 0.500

6.  The Impact of Surgical Technique on Patient Reported Outcome Measures and Early Complications After Total Hip Arthroplasty.

Authors:  Udai S Sibia; Timothy R Turner; James H MacDonald; Paul J King
Journal:  J Arthroplasty       Date:  2016-11-01       Impact factor: 4.757

7.  How Fast Should a Total Knee Arthroplasty Be Performed? An Analysis of 140,199 Surgeries.

Authors:  Jaiben George; Bilal Mahmood; Assem A Sultan; Nipun Sodhi; Michael A Mont; Carlos A Higuera; Kim L Stearns
Journal:  J Arthroplasty       Date:  2018-03-13       Impact factor: 4.757

8.  Posterolateral vs Direct Anterior Approach in Total Hip Arthroplasty (POLADA Trial): A Randomized Controlled Trial to Assess Differences in Serum Markers.

Authors:  Kyrill Rykov; Inge H F Reininga; Maurits S Sietsma; Bas A S Knobben; Bas L E F Ten Have
Journal:  J Arthroplasty       Date:  2017-07-14       Impact factor: 4.757

9.  High complication rate with anterior total hip arthroplasties on a fracture table.

Authors:  Brian A Jewett; Dennis K Collis
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

10.  Factors predisposing to dislocation after primary total hip arthroplasty: a multivariate analysis.

Authors:  B M Jolles; P Zangger; P-F Leyvraz
Journal:  J Arthroplasty       Date:  2002-04       Impact factor: 4.757

View more
  3 in total

1.  Activities and participation after primary total hip arthroplasty; posterolateral versus direct anterior approach in 860 patients.

Authors:  Daisy A J M Latijnhouwers; Niels Laas; Suzan H M Verdegaal; Rob G H H Nelissen; Thea P M Vliet Vlieland; Herman H Kaptijn; Maaike G J Gademan
Journal:  Acta Orthop       Date:  2022-07-04       Impact factor: 3.925

2.  Application of a novel osteotomy instrumentation as a substitute tool in total hip arthroplasty.

Authors:  Yuehao Hu; Jingwei Zhang; Ziyang Sun; Degang Yu; Huiwu Li; Zhenan Zhu; Yuanqing Mao; Mengning Yan; Zanjing Zhai
Journal:  BMC Musculoskelet Disord       Date:  2022-05-11       Impact factor: 2.562

3.  Bone Density May Be a Promising Predictor for Blood Loss during Total Hip Arthroplasty.

Authors:  Wei Zhu; Zhanqi Wei; Tianjun Zhou; Chang Han; Zehui Lv; Han Wang; Bin Feng; Xisheng Weng
Journal:  J Clin Med       Date:  2022-07-07       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.